Indo US Bio-Tech

Market Cap: Micro Cap
Industry: Other Agricultural Products
ISIN: INE250Z01010
NSEID: INDOUS
BSEID: 541304

INR

131.65

2.55 (1.98%)

BSENSE

Dec 05

BSE+NSE Vol: 28.46 k

{
  "main_header": {
    "sid": 1002989,
    "name": "Indo US Bio-Tech",
    "stock_name": "Indo US Bio-Tech",
    "full_name": "Indo US Bio-Tech Ltd",
    "name_url": "stocks-analysis/indo-us-bio-tech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "131.65",
    "chg": 2.55,
    "chgp": "1.98%",
    "dir": 1,
    "prev_price": "129.10",
    "mcapval": "263.98 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541304,
    "symbol": "INDOUS",
    "ind_name": "Other Agricultural Products",
    "ind_code": 61,
    "indexname": "",
    "isin": "INE250Z01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "28.46 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indo-us-bio-tech-1002989-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indo US Bio-Tech Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indo-us-bio-tech-upgraded-from-sell-to-hold-by-marketsmojo-on-27-nov-2025-3743905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/IndoUSBioTech_mojoScore_3743905.png",
        "date": "2025-12-03 11:08:35",
        "description": "Indo US Bio-Tech, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This adjustment comes amid a backdrop of mixed financial performance and subdued stock returns over the past year."
      },
      {
        "title": "Why is Indo US Bio-Tech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-indo-us-bio-tech-fallingrising-3736257",
        "imagepath": "",
        "date": "2025-11-29 01:04:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Volatility and Price Movement</strong></p>\n<p>The stock experienced significant intraday fluctuations, with a volatility measure of 6.89%, reflecting a turbulent trading session. It touched an intraday low of ₹135, marking an 8.63% drop from previous levels. The weighted average price indicated that a larger volume of shares was traded closer to this lower price point, suggesting selling pressure dominated the session.</p>\n<p><strong>Trend Reversal After Recent Gains</strong></p>\n<p>After two days of consecutive gains, the stock’s fall on 28 Nov represents a clear trend reversal. This shift indicates that the recent buying momentum has paused, and profit-taking or cautious sentiment may have set in among investors. The underperformance relative to its sector, lagging by 7.35% today,..."
      },
      {
        "title": "How has been the historical performance of Indo US Bio-Tech?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-indo-us-bio-tech-3734112",
        "imagepath": "",
        "date": "2025-11-27 22:45:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the three-year period ending March 2022, Indo US Bio-Tech's net sales increased from ₹39.76 crores in FY20 to ₹50.06 crores in FY22, reflecting a compound growth trajectory. The total operating income mirrored this trend, with no other operating income reported during these years. Notably, the operating profit before depreciation, interest, and tax (PBDIT) rose from ₹3.98 crores in FY20 to ₹6.95 crores in FY22, indicating enhanced operational efficiency. The operating profit margin improved from 10.01% in FY20 to 13.52% in FY22, underscoring better cost management despite fluctuations in raw material costs and purchase of finished goods.</p>\n<p>Profit before tax (PBT) showed a consistent upward movement, climbing from ₹2.86 crores in FY20..."
      },
      {
        "title": "Indo US Bio-Tech Surges to Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-surges-20-to-hit-upper-circuit-amid-robust-buying-pressure-3731377",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_stocks_hitting_upper_circuit_3731377.png",
        "date": "2025-11-26 12:00:12",
        "description": "Indo US Bio-Tech Ltd witnessed a remarkable trading session on 26 Nov 2025, hitting its upper circuit limit with a near 20% gain. The stock's surge was driven by intense buying interest, resulting in a regulatory freeze on further transactions and highlighting significant unfilled demand in the market."
      },
      {
        "title": "Indo US Bio-Tech Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-surges-to-upper-circuit-amid-unprecedented-buying-interest-3731334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_only_buyers_3731334.png",
        "date": "2025-11-26 11:35:40",
        "description": "Indo US Bio-Tech Ltd witnessed extraordinary buying momentum on 26 Nov 2025, registering a remarkable 19.98% gain in a single trading session. The stock's price action was characterised by an upper circuit scenario with exclusively buy orders in the queue, signalling intense demand and a potential multi-day circuit continuation."
      },
      {
        "title": "Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-stock-falls-to-52-week-low-of-rs1126-amid-market-underperformance-3728771",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_priceRelatedfactors_3728771.png",
        "date": "2025-11-25 10:53:49",
        "description": "Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline in its stock price amid broader market gains and sectoral advances. The stock's recent performance contrasts sharply with the positive momentum observed in the agricultural sector and the wider market indices."
      },
      {
        "title": "Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-stock-hits-52-week-low-amidst-continued-downtrend-3728770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_priceRelatedfactors_3728770.png",
        "date": "2025-11-25 10:53:47",
        "description": "Indo US Bio-Tech's stock reached a fresh 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock's recent performance contrasts sharply with the overall positive momentum in the agricultural products sector and the wider market indices."
      },
      {
        "title": "Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-stock-falls-to-52-week-low-of-rs1126-3728769",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_priceRelatedfactors_3728769.png",
        "date": "2025-11-25 10:53:46",
        "description": "Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural sector and the broader Sensex index."
      },
      {
        "title": "Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indo-us-bio-tech-stock-falls-to-52-week-low-of-rs1126-3728772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndoUSBioTech_priceRelatedfactors_3728772.png",
        "date": "2025-11-25 10:53:41",
        "description": "Indo US Bio-Tech’s stock price reached a new 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural products sector and the wider market indices."
      }
    ],
    "total": 205,
    "sid": "1002989",
    "stock_news_url": "https://www.marketsmojo.com/news/indo-us-bio-tech-1002989"
  },
  "announcements": [
    {
      "caption": "Indo US Biotech Limited Is Proud To Announce Its Participation In The APSA Seed Congress 2025 Taking Place In Mumbai From 17Th To 20Th November 2025.",
      "datetime": "17-Nov-2025",
      "details": "Announcement under Regulation 30 of SEBI LODR",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Newspaper Advertisement relating to Unaudited Quarterly and Half Yearly Standalone Financial Results for the Quarter and Half year ended on 30th Sept. 2025.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "14-Nov-2025",
      "details": "Results of Postal Ballot by Remote E voting Process and Scrutinizers Report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has declared <strong>2%</strong> dividend, ex-date: 03 Dec 24",
          "dt": "2024-12-03",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Indo US Bio-Tech Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Aug 23",
          "dt": "2023-08-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indo US Bio-Tech Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-12-03 11:08:35

Indo US Bio-Tech, a microcap player in the Other Agricultural Products sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across quality, valuation, financial trends, and technical outlook. This adjustment comes amid a backdrop of mixed financial performance and subdued stock returns over the past year.

Why is Indo US Bio-Tech falling/rising?

2025-11-29 01:04:30

Intraday Volatility and Price Movement

The stock experienced significant intraday fluctuations, with a volatility measure of 6.89%, reflecting a turbulent trading session. It touched an intraday low of ₹135, marking an 8.63% drop from previous levels. The weighted average price indicated that a larger volume of shares was traded closer to this lower price point, suggesting selling pressure dominated the session.

Trend Reversal After Recent Gains

After two days of consecutive gains, the stock’s fall on 28 Nov represents a clear trend reversal. This shift indicates that the recent buying momentum has paused, and profit-taking or cautious sentiment may have set in among investors. The underperformance relative to its sector, lagging by 7.35% today,...

How has been the historical performance of Indo US Bio-Tech?

2025-11-27 22:45:33

Revenue and Profitability Trends

Over the three-year period ending March 2022, Indo US Bio-Tech's net sales increased from ₹39.76 crores in FY20 to ₹50.06 crores in FY22, reflecting a compound growth trajectory. The total operating income mirrored this trend, with no other operating income reported during these years. Notably, the operating profit before depreciation, interest, and tax (PBDIT) rose from ₹3.98 crores in FY20 to ₹6.95 crores in FY22, indicating enhanced operational efficiency. The operating profit margin improved from 10.01% in FY20 to 13.52% in FY22, underscoring better cost management despite fluctuations in raw material costs and purchase of finished goods.

Profit before tax (PBT) showed a consistent upward movement, climbing from ₹2.86 crores in FY20...

Indo US Bio-Tech Surges to Upper Circuit Amid Strong Buying Pressure

2025-11-26 12:00:12

Indo US Bio-Tech Ltd witnessed a remarkable trading session on 26 Nov 2025, hitting its upper circuit limit with a near 20% gain. The stock's surge was driven by intense buying interest, resulting in a regulatory freeze on further transactions and highlighting significant unfilled demand in the market.

Indo US Bio-Tech Surges with Unprecedented Buying Interest, Hits Upper Circuit

2025-11-26 11:35:40

Indo US Bio-Tech Ltd witnessed extraordinary buying momentum on 26 Nov 2025, registering a remarkable 19.98% gain in a single trading session. The stock's price action was characterised by an upper circuit scenario with exclusively buy orders in the queue, signalling intense demand and a potential multi-day circuit continuation.

Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance

2025-11-25 10:53:49

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline in its stock price amid broader market gains and sectoral advances. The stock's recent performance contrasts sharply with the positive momentum observed in the agricultural sector and the wider market indices.

Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance

2025-11-25 10:53:47

Indo US Bio-Tech's stock reached a fresh 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock's recent performance contrasts sharply with the overall positive momentum in the agricultural products sector and the wider market indices.

Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance

2025-11-25 10:53:46

Indo US Bio-Tech has reached a new 52-week low of Rs.112.6, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural sector and the broader Sensex index.

Indo US Bio-Tech Falls to 52-Week Low of Rs.112.6 Amid Market Underperformance

2025-11-25 10:53:41

Indo US Bio-Tech’s stock price reached a new 52-week low of Rs.112.6 today, marking a significant decline amid broader market gains and sectoral strength. The stock’s recent performance contrasts sharply with the positive momentum seen in the agricultural products sector and the wider market indices.

View All News

Announcement

Indo US Biotech Limited Is Proud To Announce Its Participation In The APSA Seed Congress 2025 Taking Place In Mumbai From 17Th To 20Th November 2025.

17-Nov-2025 | Source : BSE

Announcement under Regulation 30 of SEBI LODR

Announcement under Regulation 30 (LODR)-Newspaper Publication

15-Nov-2025 | Source : BSE

Newspaper Advertisement relating to Unaudited Quarterly and Half Yearly Standalone Financial Results for the Quarter and Half year ended on 30th Sept. 2025.